According to GlobalData’s medical device pipeline database, 131 Parasitology & Mycology Rapid Tests & POC devices are in various stages of development globally. GlobalData’s report Parasitology & Mycology Rapid Tests & POC provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 59 are in active development, while the remaining 72 are in an inactive stage of development. There are 48 products in the early stages of development, and the remaining 11 are in the late stages of development.
In Vitro Diagnostics (IVD) include reagents, instruments and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. This sub-segment comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Plasmodium and Candida albicans.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Parasitology & Mycology Rapid Tests & POC pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Parasitology & Mycology Rapid Tests & POC devices. Overall, most of these Parasitology & Mycology Rapid Tests & POC pipeline devices are being developed by private entities.
Key players involved in the active development of Parasitology & Mycology Rapid Tests & POC include DxDiscovery, Kephera Diagnostics, Molbio Diagnostics, Cellabs, Guangzhou Wondfo Biotech, Mologic, Micronics, Cambridge Nutritional Sciences, Institute for Development Research and Johns Hopkins University.
For a complete picture of the developmental pipeline for Parasitology & Mycology Rapid Tests & POC devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.